Filing Flows

Filing Flows › Companies › Arteris › Cash flow

Arteris cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$2.1M in Q3 2026 · $2.2M over twelve months

Operating cash flow−$1.8M
Capital spending−$375K
Free cash flow−$2.1M
Cash conversion cycle37 days

Analysis

In Q3 2026, Arteris generated −$1.8M of operating cash flow and spent $375K on capital projects, leaving free cash flow of −$2.1M. That is $4.6M less than in Q3 2025 ($2.5M).

Over the twelve months to Sep 30, 2026, operating cash flow was $3.6M; the largest uses were other investing ($21.7M), capital spending ($1.4M); besides operations, cash came from other financing ($71.5M), shares issued ($1.6M); the cash balance rose by $53.5M.

Operating cash flow was −$1.8M against net income of −$11.2M. The largest differences: stock-based pay +$9.2M, receivables −$5.7M, deferred revenue +$3.2M.

Its cash conversion cycle was 37 days (receivables 65 + inventory 0 − payables 27).

Free cash flow

Arteris: free cash flow by quarterArteris: free cash flow by quarter−$2.7MQ4 2024$2.7MQ1 2025−$2.8MQ2 2025$2.5MQ3 2025$3.0MQ4 2025−$7.4MQ1 2026$8.6MQ2 2026−$2.1MQ3 2026
Operating cash flow less capital spending.
Arteris: operating cash flow against capital spendingArteris: operating cash flow against capital spendingOperating cash flowCapital spending−$2.6M$50KQ4 2024$2.9M$183KQ1 2025−$2.5M$355KQ2 2025$3.2M$716KQ3 2025$3.2M$134KQ4 2025−$7.1M$295KQ1 2026$9.2M$595KQ2 2026−$1.8M$375KQ3 2026
Latest (Q3 2026): Operating cash flow −$1.8M, Capital spending $375K.

Capital allocation, year by year

Arteris: where the cash came from (up) and went (down), by fiscal yearArteris: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingAcquisitionsFY2021: Operating cash flow −$814KFY2021: Net borrowing −$550KFY2021: Shares issued $6.0MFY2021: Capital spending −$808K$6.0MFY2021FY2022: Operating cash flow −$6.8MFY2022: Shares issued $876KFY2022: Capital spending −$1.1MFY2022: Acquisitions −$1.1M$876KFY2022FY2023: Operating cash flow −$15.7MFY2023: Shares issued $490KFY2023: Capital spending −$1.5M$490KFY2023FY2024: Operating cash flow −$720KFY2024: Shares issued $890KFY2024: Capital spending −$324K$890KFY2024FY2025: Operating cash flow $6.7MFY2025: Shares issued $1.9MFY2025: Capital spending −$1.4M$8.6MFY2025
Over these 5 years operating cash flow totalled −$17.3M; the largest uses were operating cash flow ($24.0M) and capital spending ($5.1M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$92.6M
Debtnone
Net cash$92.6M
Cash runwaymore than 10 years

Arteris is burning cash: its operations consume cash, a free cash flow of −$8.5M a year at the current rate against $92.6M of cash and investments: a runway of more than ten years at that rate before any new financing.

Where the cash came from and went

Arteris: sources (+) and uses (−) of cash, Q3 2026Arteris: sources (+) and uses (−) of cash, Q3 2026Cash drawn (+) / kept (−)$22.3MOther investing−$19.4MOperating cash flow−$1.8MOther financing−$419KCapital spending−$375KShares issued−$305K
Arteris: sources (+) and uses (−) of cash, TTM to Q3 2026Arteris: sources (+) and uses (−) of cash, TTM to Q3 2026Other financing$71.5MCash drawn (+) / kept (−)−$53.5MOther investing−$21.7MOperating cash flow$3.6MShares issued$1.6MCapital spending−$1.4M

From profit to cash

Arteris: net income to operating cash flow, Q3 2026Arteris: net income to operating cash flow, Q3 2026Net income−$11.2MDepreciation & amortization$1.5MStock-based pay$9.2MOther non-cash$102KReceivables−$5.7MPayables$910KAccrued liabilities$1.2MDeferred revenue$3.2MPrepaid and other assets−$581KOperating cash flow−$1.8M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 202665—2737
Q2 202656—1442
Q1 202666—1354
Q4 202581—2160
Q3 202593—3657
Q2 202580—2852
Q1 202584—2361
Q4 202487—2067

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsShares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026−$1.8M−$375K—−$305K$22.3M−$2.1M
Q2 2026$9.2M−$595K—$72.4M−$81.6M$8.6M
Q1 2026−$7.1M−$295K−$11.2M$1.2M$22.2M−$7.4M
Q4 2025$3.2M−$134K—$343K−$16.4M$3.0M
Q3 2025$3.2M−$716K—$71K−$1.4M$2.5M
Q2 2025−$2.5M−$355K—$1.3M$272K−$2.8M
Q1 2025$2.9M−$183K—$148K−$2.7M$2.7M
Q4 2024−$2.6M−$50K—$187K$4.1M−$2.7M

Arteris: income statement and cash flow

Arteris, Q3 2026: revenue $25.8M (+48% year over year), operating margin -43.9%. The chart follows the revenue to costs, profit and cash.

Arteris: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.